Altamont Capital saw a 300% increase in team's platform engagement when switching to AlphaSense
Altamont Capital Partners, a Silicon Valley private equity firm, switched from its legacy market-intelligence platform to AlphaSense to fix data inconsistencies and improve research efficiency. Teams adopted AlphaSense's AI-powered search, Smart Summaries, and Table Tools to streamline due-diligence workflows and synthesize broker-report and news insights faster. The page states this drove a 300% increase in platform engagement versus the prior tool, attributed to ease of search, data consistency, and a smoother user experience.
AlphaSense is an AI-powered search platform over premium business documents, earnings calls, filings and expert-network transcripts, used by pharma competitive-intelligence and business-development teams.
This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.
Published by AlphaSense on its own site — read the original case study on alpha-sense.com ↗
Related use cases
- 013M overcomes information overload with AlphaSense
- 02AlphaSense gives 3T a "one-stop-shop" to accelerate their research
- 03Arogyam Health Intelligence Chooses AlphaSense for Fast, Money-Saving Intelligence
- 04A BioPharma Insights Company uses AlphaSense to Get Granular on Industry Insights
- 05A biotech investor taps internal and external content for insights
- 06Cardinal Health accelerates their research process